Signal Point Hematology is categorized under Hematologists in Middletown, OH and active since 1990.
Signal Point Hematology was established in 1990, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Hematologists business, which does work in the B2C market, and is classified as a Hematologists, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Cheryl A Skinner at the company’s single location by writing to 235 North Breiel Boulevard, Middletown, Ohio OH 45042 or by phoning (513) 423-0504. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Signal Point Hematology |
| Contact Person: | Cheryl A Skinner |
| Address: | 235 North Breiel Boulevard, Middletown, Ohio 45042 |
| Phone Number: | (513) 423-0504 |
| Website Address: | signalpointcrc.com |
| Annual Revenue (USD): | $2.500.000 to $4.999.999 |
| Founded: | 1990 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Hematologists |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Signal Point Hematology was started in 1990 to provide professional Hematologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Cheryl A Skinner for inquiries that concern Signal Point Hematology by calling the company number (513) 423-0504, as your correspondence is most welcome. Additionally, the physical location of the single location of Signal Point Hematology can be found at the coordinates 39.5151,-84.35413 as well as the street address 235 North Breiel Boulevard in Middletown, Ohio 45042.
For its online presence, you may visit Signal Point Hematology’s website at signalpointcrc.com and engage with its social media outlets through on Twitter and on Facebook.